Estradiol-estrogen receptor: A key interplay of the expression of syndecan-2 and metalloproteinase-9 in breast cancer cells

Molecular Oncology

Volumn 2, Issue 3, 2008, Pages 223-232

  Kousidou, Olga Ch ^a   Berdiaki, Aikaterini ^b   Kletsas, Dimitris ^c   Zafiropoulos, Alexandros ^b   Theocharis, Achilleas D ^a   Tzanakakis, George N ^b   Karamanos, Nikos K ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b UNIVERSITY OF CRETE   (Greece)

^c Institute of Biology   (Greece)

Author keywords

Breast cancer; Estradiol; Estrogen receptor ; Metalloproteinases; Proteoglycans; Tissue inhibitors of metalloproteinases

Indexed keywords

ESTRADIOL RECEPTOR; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GELATINASE B; PROTEOGLYCAN; SYNDECAN 2; SYNDECAN 4; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ARTICLE; BREAST CANCER; CANCER CELL; CELL CULTURE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BREAST NEOPLASMS; CELL LINE, TUMOR; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASE 9; RECEPTORS, ESTROGEN; SYNDECAN-2; SYNDECAN-4; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 51449094588     PISSN: 15747891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molonc.2008.06.002     Document Type: Article

References (47)

1. Alarid E.T., Bakopoulos N., and Solodin N. Proteasome-mediated proteolysis of estrogen receptor: a novel component in autologous down-regulation. Mol. Endocrinol 13 (1999) 1522-1534
2. Ali S., and Coombes R.C. Estrogen receptor alpha in human breast cancer: occurrence and significance. J. Mammary Gland Biol. Neoplasia 5 (2000) 271-281
3. Beauvais D.L.M., and Rapraeger A. Syndecans in tumor cell adhesion and signaling. Reprod. Biol. Endocrinol 2 (2004) 1-12
4. Borras M., Hardy L., Lempereur F., El Khissiin A.H., Legros N., Gol-Winkler R., and Leclercq G. Estradiol-induced down-regulation of estrogen receptor. Effect of various modulators of protein synthesis and expression. J. Steroid Biochem. Mol. Biol. 48 (1994) 325-336
5. Capony F., Morisset M., Barrett A.J., Capony J.P., Broquet P., Vignon F., Chambon M., Louisot P., and Rochefort H. Phosphorylation, glycosylation, and proteolytic activity of the 52-kD estrogen-induced protein secreted by MCF-7 cells. J. Cell Biol. 104 (1987) 253-262
6. Dobra K., Andäng M., Syrokou A., Karamanos N.K., and Hjerpe A. Differentiation of mesothelioma cells is influenced by the expression of proteoglycans. Exp. Cell Res. 258 (2000) 12-22
7. Egeblad M., and Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2 (2002) 161-174
8. El Khissiin A., and Leclercq G. Implication of proteasome in estrogen receptor degradation. FEBS Lett. 448 (1999) 160-166
9. Elkin M., Cohen I., Zcharia E., Orgel A., Guatta-Rangini Z., Peretz T., Vlodavsky I., and Kleinman H. Regulation of heparanase gene expression by estrogen in breast cancer. Cancer Res. 63 (2003) 8821-8826
10. Essner J.J., Chenb E., and Ekker S.C. Syndecan-2. Int. J. Biochem. Cell Biol. 38 (2006) 152-156
11. Fan M., Nakshatri H., and Nephew K.P. Inhibiting proteasomal proteolysis sustains estrogen receptor-alpha activation. Mol. Endocrinol 18 (2004) 2603-2615
12. Fernandez H.A., Kallenbach K., Seghezzi G., Grossi E., Colvin S., Schneider R., Mignatti P., and Galloway A. Inhibition of endothelial cell migration by gene transfer of tissue inhibitor of metalloproteinases-1. J. Surg. Res. 82 (1999) 156-162
13. Gustafsson J.A., and Warner M. Estrogen receptor beta in the breast: role in estrogen responsiveness and development of breast cancer. J. Steroid Biochem. Mol. Biol. 74 (2000) 245-248
14. Han I., Park H., and Oh E.S. New insights into syndecan-2 expression and tumorigenic activity in colon carcinoma cells. J. Mol. Histol 35 (2004) 319-326
15. Haslam S.Z., and Nummy K.A. The ontogeny and cellular distribution of estrogen receptors in normal mouse mammary gland. J. Steroid Biochem. Mol. Biol. 42 (1992) 589-595
16. Haslam S.Z., and Woodward T.L. Reciprocal regulation of extracellular matrix proteins and ovarian steroid activity in the mammary gland. Breast Cancer Res. 3 (2001) 365-372
17. Henderson B.E., and Feigelson H.S. Hormonal carcinogenesis. Carcinogenesis 21 (2000) 427-433
18. Jayson G.C., Vives C., Paraskeva C., Schofield K., Coutts J., Fleetwood A., and Gallagher J.T. Coordinated modulation of the fibroblast growth factor dual receptor mechanism during transformation from human colon adenoma to carcinoma. Int. J. Cancer 82 (1999) 298-304
19. Jensen E.V., and Jordan V.C. The estrogen receptor: a model for molecular medicine. Clin. Cancer Res. 9 (2003) 1980-1989
20. Khan S.A., Rogers M.A., Khurana K.K., Meguid M.M., and Numann P.J. Estrogen receptor expression in benign breast epithelium and breast cancer risk. J. Natl. Cancer Inst 90 (1998) 37-42
21. Kousidou O.Ch., Mitropoulou T.N., Roussidis A.E., Kletsas D., Theocharis A.D., and Karamanos N.K. Genistein suppresses the invasive potential of human breast cancer cells through transcriptional regulation of metalloproteinases and their tissue inhibitors. Int. J. Oncol 26 (2005) 1101-1109
22. Kuiper G.G.J.M., Carlsson B., Grandien K., and Enmark E. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta Endocrinology 138 (1997) 863-870
23. Laïos I., Journé F., Nonclercq D., Vidal D.S., Toillon R.A., Laurent G., and Leclercq G. Role of the proteasome in the regulation of estrogen receptor alpha turnover and function in MCF-7 breast carcinoma cells. J. Steroid Biochem. Mol. Biol. 94 (2005) 347-359
24. Lafleur M.A., Handsley M.M., Knauper V., Murphy G., and Edwards D.R. Endothelial tubulogenesis within fibrin gels specifically requires the activity of membrane-type-matrix metalloproteinases (MT-MMPs). J. Cell Sci. 115 (2002) 3427-3438
25. Li G., Fridman R., and Kim H.R. Tissue inhibitor of metalloproteinase-1 inhibits apoptosis of human breast epithelial cells. Cancer Res. 59 (1999) 6267-6275
26. Liotta L.A., and Kohn E.C. The microenvironment of the tumour-host interface. Nature 411 (2001) 375-379
27. Losordo D.W., and Isner J.M. Estrogen and angiogenesis: A review. Arterioscler Thromb. Vasc. Biol. 21 (2001) 6-12
28. Luparello C., Avanzato G., Carella C., and Pucci-Minafra I. Tissue inhibitor of metalloprotease (TIMP)-1 and proliferative behaviour of clonal breast cancer cells. Breast Cancer Res. Treat 54 (1999) 235-244
29. McDonnell D.P., and Norris J.D. Connections and regulation of the human estrogen receptor. Science 296 (2002) 1642-1644
30. Mitropoulou T.N., Tzanakakis G.N., Kletsas D., Kalofonos H.P., and Karamanos N.K. Letrozole as a potent inhibitor of cell proliferation and expression of metalloproteinases (MMP-2 and MMP-9) by human epithelial breast cancer cells. Int. J. Cancer 104 (2003) 155-160
31. Nilsson U., Garvin S., and Dabrosin C. MMP-2 and MMP-9 activity is regulated by estradiol and tamoxifen in cultured human breast cancer cells. Breast Cancer Res. Treat 102 (2007) 253-261
32. Paech K., Webb P., Kuiper G.G., Nilsson S., Gustatsson J., Kushner P.J., and Scanlan T.S. Differential ligand activation of estrogen receptors ERα and ERβ at AP-1 sites. Science 277 (1997) 1508-1510
33. Palmieri C., Cheng G.J., Saji S., Zelada-Hedman M., Warri A., Weihua Z., Van Noorden S., Wahlstrom T., Coombes R.C., Warner M., and Gustafsson J.A. Endocrine-Related Cancer 9 (2002) 1-13
34. Pang H., and Faber L.E. Estrogen and rapamycin effects on cell cycle progression in T47D breast cancer cells. Breast Cancer Res. Treat 70 (2001) 21-26
35. Park H., Kim Y., Lim Y., Han I., and Oh E.S. Syndecan-2 mediates adhesion and proliferation of colon carcinoma cells. J. Biol. Chem. 277 (2002) 29730-29736
36. Rochefort H., Capony F., Garcia M., Cavailles V., Freiss G., Chambon M., Morisset M., and Vignon F. Estrogen-induced lysosomal proteases secreted by breast cancer cells: A role in carcinogenesis?. J. Cell. Biochem 35 (1987) 17-29
37. Ruohola J.K., Valve E.M., Karkkainen M.J., Joukov V., Alitalo K., and Harkonen P.L. Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells. Mol. Cell Endocrinol 149 (1999) 29-40
38. Russo J., Ao X., Grill C., and Russo I.H. Pattern of distribution of cells positive for estrogen receptor alpha and progesterone receptor in relation to proliferating cells in the mammary gland. Breast Cancer Res. Treat 53 (1999) 217-227
39. Saceda M., Lippman M.E., Chambon P., Lindsey R.L., Ponglikitmongkol M., Puente M., and Martin M.B. Regulation of the estrogen receptor in MCF-7 cells by estradiol. Mol. Endocr 2 (1988) 1157-1162
40. Shekhar M.P., Werdell J., Santner S.J., Pauley R.J., and Tait L. Breast stroma plays a dominant regulatory role in breast epithelial growth and differentiation: implications for tumor development and progression. Cancer Res. 61 (2001) 1320-1326
41. Shoker B.S., Jarvis C., Sibson D.R., Walker C., and Sloane J.R. Oestrogen receptor expression in the normal and pre-cancerous breast. J. Pathol 188 (1999) 237-244
42. Stahtea X.N., Roussidis A.E., Kanakis I., Tzanakakis G.N., Chalkiadakis G., Mavroudis D., Kletsas D., and Karamanos N.K. Imatinib inhibits colorectal cancer cell growth and suppresses stromal-induced growth stimulation, MT1-MMP expression and pro-MMP2 activation. Int J. Cancer 121 (2007) 2808-2814
43. Sternlicht M.D., and Werb Z. How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 17 (2001) 463-516
44. Tateishi Y., Kawabe Y., Chiba T., Murata S., Ichikawa K., Murayama A., Tanaka K., Baba T., Kato S., and Yanagisawa J. Ligand-dependent switching of ubiquitin-proteasome pathways for estrogen receptor. EMBO J 23 (2004) 4813-4823
45. Tkachenko E., Rhodes J.M., and Simons M. Syndecans: new kids on the signaling block. Circ. Res. 96 (2005) 488-500
46. Welgus H.G., and Stricklin G.P. Human skin fibroblast collagenase inhibitor. Comparative studies in human connective tissues, serum, and amniotic fluid. J. Biol. Chem. 258 (1983) 12259-12264
47. Wingrove C.S., Garr E., Godsland I.F., and Stevenson J.C. 17beta-oestradiol enhances release of matrix metalloproteinase-2 from human vascular smooth muscle cells. Biochim. Biophys. Acta 1406 (1998) 169-174